These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36527248)

  • 1. Symptom and performance validity in neuropsychological assessments of outpatients 15-30 years of age.
    Boe EW; Evald L
    Brain Inj; 2022 Dec; ():1-7. PubMed ID: 36527248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance and Symptom Validity Assessment in Patients with Apathy and Cognitive Impairment.
    Dandachi-FitzGerald B; Duits AA; Leentjens AFG; Verhey FRJ; Ponds RWHM
    J Int Neuropsychol Soc; 2020 Mar; 26(3):314-321. PubMed ID: 31658930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the relationship between symptom and performance validity measures across referral subtypes.
    Boress K; Gaasedelen O; Kim JH; Basso MR; Whiteside DM
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):162-171. PubMed ID: 37791494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance validity and symptom validity tests: Are they measuring different constructs?
    Ord AS; Shura RD; Sansone AR; Martindale SL; Taber KH; Rowland JA
    Neuropsychology; 2021 Mar; 35(3):241-251. PubMed ID: 33829824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive Analysis of MMPI-2-RF Symptom Validity Scales and Performance Validity Test Relationships in a Diverse Mixed Neuropsychiatric Setting.
    De Boer AB; Phillips MS; Barwegen KC; Obolsky MA; Rauch AA; Pesanti SD; Tse PKY; Ovsiew GP; Jennette KJ; Resch ZJ; Soble JR
    Psychol Inj Law; 2023; 16(1):61-72. PubMed ID: 36348958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Types or modes of malingering? A confirmatory factor analysis of performance and symptom validity tests.
    Egeland J; Andersson S; Sundseth ØØ; Schanke AK
    Appl Neuropsychol Adult; 2015; 22(3):215-26. PubMed ID: 25275555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Korsakoff Amnesia on performance and symptom validity testing.
    Oudman E; Krooshof E; van Oort R; Lloyd B; Wijnia JW; Postma A
    Appl Neuropsychol Adult; 2020; 27(6):549-557. PubMed ID: 30848959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Performance Validity Measures in Predicting MMPI-2 Lie Scale Results.
    Richey LN; Doninger NA
    Clin Neuropsychol; 2020 Feb; 34(2):353-367. PubMed ID: 31340718
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor symptom and performance validity in regularly referred Hospital outpatients: Link with standard clinical measures, and role of incentives.
    Dandachi-FitzGerald B; van Twillert B; van de Sande P; van Os Y; Ponds RW
    Psychiatry Res; 2016 May; 239():47-53. PubMed ID: 27137961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distress Tolerance and Symptom Severity as Mediators of Symptom Validity Failure in Veterans With PTSD.
    Miskey HM; Martindale SL; Shura RD; Taber KH
    J Neuropsychiatry Clin Neurosci; 2020; 32(2):161-167. PubMed ID: 31266409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective Cognitive Outcomes and Subjective Emotional Sequelae in Litigating Adults with a Traumatic Brain Injury: The Impact of Performance and Symptom Validity Measures.
    Uiterwijk D; Stargatt R; Crowe SF
    Arch Clin Neuropsychol; 2022 Nov; 37(8):1662-1687. PubMed ID: 35704852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Evaluation Board Involvement, Non-Credible Cognitive Testing, and Emotional Response Bias in Concussed Service Members.
    Mooney SR; Stafford J; Seats E
    Mil Med; 2018 Nov; 183(11-12):e546-e554. PubMed ID: 29590406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting coached neuropsychological dysfunction: a simulation experiment regarding mild traumatic brain injury.
    Lau L; Basso MR; Estevis E; Miller A; Whiteside DM; Combs D; Arentsen TJ
    Clin Neuropsychol; 2017 Nov; 31(8):1412-1431. PubMed ID: 28415909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of validity testing in psychiatric assessment: evidence from a sample of multimorbid post-9/11 veterans.
    Kim S; Currao A; Brown E; Milberg WP; Fortier CB
    J Int Neuropsychol Soc; 2024 May; 30(4):410-419. PubMed ID: 38014547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidimensional Malingering Criteria for Neuropsychological Assessment: A 20-Year Update of the Malingered Neuropsychological Dysfunction Criteria.
    Sherman EMS; Slick DJ; Iverson GL
    Arch Clin Neuropsychol; 2020 Aug; 35(6):735-764. PubMed ID: 32377667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of informant report interpretations: Role of examinee performance and symptom invalidity.
    Webber TA; Sullivan-Baca E; Modiano YA; Taiwo Z; Grabyan JM
    Psychol Assess; 2022 Feb; 34(2):125-138. PubMed ID: 34647761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Underperformance in a Mixed Neuropsychiatric Sample at Diagnostic Evaluation of Adult ADHD.
    Dong H; Koerts J; Pijnenborg GHM; Scherbaum N; Müller BW; Fuermaier ABM
    J Clin Med; 2023 Nov; 12(21):. PubMed ID: 37959391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of performance validity testing and symptom validity testing in psychoeducational assessment.
    Harrison AG; Beal AL; Armstrong IT
    Appl Neuropsychol Adult; 2023; 30(3):315-329. PubMed ID: 34261385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Adverse Childhood Experiences on Symptom and Performance Validity Tests Among a Multiracial Sample Presenting for ADHD Evaluation.
    Gonzalez C; Finley JA; Khalid E; Basurto KS; VanLandingham HB; Frick LA; Brooks JM; Ellison RL; Ulrich DM; Soble JR; Resch ZJ
    Arch Clin Neuropsychol; 2024 Aug; 39(6):692-701. PubMed ID: 38366222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.